Atlas Trials

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Clinical trial NCT01363479 · COMPLETED

Trial details

NCT number
NCT01363479
Sponsor
Helsinn Healthcare SA
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chemotherapy-Induced Nausea and Vomiting
Start date
2011-07-01
Primary completion
2012-11-01
Enrollment
743

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.